Table 1.
Summary of participants’ baseline characteristics.
| Variable | Group 1 Low dose (n = 6) | Group 2 Intermediate dose (n = 9) | Group 3 High dose (n = 9) | All Groups (n = 24) |
|---|---|---|---|---|
| Age | ||||
| Median | 43 | 26 | 24 | 29 |
| Range | 20–45 | 18–41 | 21–43 | 18–45 |
| Sex | ||||
| Male – n (%) | 2 (33·33) | 2 (22·22) | 2 (22·22) | 6 (25) |
| Female – n (%) | 4 (66·67) | 7 (77·78) | 7 (77·78) | 18 (75) |
| Ethnicity | ||||
| White – n (%) | 6 (100) | 5 (55·56) | 8 (88·89) | 19 (79·17) |
| Mixeda – n (%) | – | 1 (11·11) | – | 1 (4·17) |
| Latin American – n (%) | – | 3 (33·33) | 1 (11·11) | 4 (16·67) |
aMixed: White and Asian.